Nanotechnology Now





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > James Woolsey and Richard Foster join Lux Capital as venture partners: Former CIA Director and former McKinsey Senior Partner help Lux Capital expand its Energy and Life Sciences investment practices

Abstract:
Lux Capital, a leading venture capital firm, today announced that the Honorable R. James (Jim) Woolsey and Richard (Dick) Foster have joined the firm as Venture Partners. Woolsey will help identify novel breakthroughs and new investment opportunities in Energy that offer significant economic and environmental benefits, and can help end America's addiction to foreign energy resources. Foster will leverage his experience and network to seek new technologies and business models for Life Sciences and healthcare IT investment.

James Woolsey and Richard Foster join Lux Capital as venture partners: Former CIA Director and former McKinsey Senior Partner help Lux Capital expand its Energy and Life Sciences investment practices

New York, NY | Posted on April 26th, 2011

"We are excited to bring Jim and Dick onto the Lux Capital team," said Josh Wolfe, Managing Partner at Lux Capital. "Both are first-rate individuals, experts with tremendous intellect and a track record of meaningful success. They will be hugely valuable in working with our existing portfolio of more than 20 private companies, as well as attracting and advising the remarkable entrepreneurs and innovators we seek to back."

Mr. Woolsey is a Venture Partner with Lux Capital and Chairman of Woolsey Partners LLC. He also Chairs the Board of the Foundation for Defense of Democracies and is a Senior Fellow at Yale University's Jackson Institute for Global Affairs. Mr. Woolsey currently chairs the Strategic Advisory Group of the Washington, D.C. private equity fund, Paladin Capital Group, and he is Of Counsel to the Washington, D.C. office of the Boston-based law firm, Goodwin Procter. In the above capacities he specializes in a range of alternative energy and security issues. Mr. Woolsey previously served in the U.S. Government on five different occasions, where he held Presidential appointments in two Republican and two Democratic administrations, most recently (1993-95) as Director of Central Intelligence. From July 2002 to March 2008 Mr. Woolsey was a Vice President and officer of Booz Allen Hamilton, and then a Venture Partner with VantagePoint Venture Partners of San Bruno, California until January 2011, during which time he sourced the firm's investments in Tesla (Nasdaq: TSLA) and Solazyme. He was also previously a partner at the law firm of Shea & Gardner in Washington, DC, now Goodwin Procter, where he practiced for 22 years in the fields of civil litigation, arbitration, and mediation. Mr. Woolsey serves on a range of government, corporate, and non-profit advisory boards and chairs several, including that of the Washington firm, ExecutiveAction LLC. He serves on the National Commission on Energy Policy. He is currently Co-Chairman of the Committee on the Present Danger. He is Chairman of the Advisory Boards of the Clean Fuels Foundation and the New Uses Council, and a Trustee of the Center for Strategic & Budgetary Assessments. Previously he was Chairman of the Executive Committee of the Board of Regents of The Smithsonian Institution, and a trustee of Stanford University. Mr. Woolsey has served in the past as a member of boards of directors of a number of publicly and privately held companies, generally in fields related to technology and security, including Martin Marietta; British Aerospace, Inc.; Fairchild Industries; and Yurie Systems, Inc. In 2009, he was the Annenberg Distinguished Visiting Fellow at the Hoover Institution at Stanford University.

"Innovation in energy will be the primary challenge of our time - whether seen through the lens of national security or that of the environment," said Woolsey. "This will require a deep understanding of, as well as networks throughout, the scientific, industrial and policy communities. Lux Capital has great people and a strategic platform that provides a unique advantage in bringing energy breakthroughs to market. I look forward to working with Lux to build new companies that matter."

Richard Foster also joins Lux Capital as a Venture Partner. Mr. Foster is also Managing Partner of Investment and Advisory Services (Invaserv). Prior to forming Invaserv, Mr. Foster was a Director and Senior Partner with McKinsey & Company where he co-founded the healthcare and private equity practices. While at McKinsey, he served as a senior partner and director for 22 years and retired from the company in 2004. Foster co-founded the firm's high technology practice in the late ‘70s, the chemicals practice in the early ‘80s, the healthcare practice in the late ‘80s, and the private equity practice in the '90s. Mr. Foster has written two bestselling and award winning books on innovation: "Innovation: The Attacker's Advantage" (1986) and "Creative Destruction" (2001). He serves on the Board of Directors of: Memorial Sloan Kettering Cancer Center (Executive Committee), W. M. Keck Foundation (Executive Committee), athenahealth (Nominating & Governance Committee Chair), Trust Company of the West (Audit Committee). In addition Mr. Foster is Co-Chair of the National Academies President's Circle, Chairman, 2011 National Meeting of the Health Data Initiative (joint venture of DHHS and the IOM); Member, Yale School of Medicine Dean's Advisory Board; Member, National Research Council, Policy and Global Affairs Committee; Fellow, American Academy of Arts and Sciences. Mr. Foster was formerly a member of the board of the Council on Foreign Relations (where he serves on the Membership Committee), the Santa Fe Institute and the Oak Ridge National Laboratory. Mr. Foster is a Senior Faculty Fellow at Yale University School of Management where he teaches "Managing in Times of Rapid Change" and Healthcare Information Technology. Mr. Foster received his BS, MS, and PhD from Yale University in Engineering and Applied Science.

"Lux Capital thinks differently from most venture investors—a distinct edge in the investment business," said Foster. "The team's enthusiasm and experience in building companies from scratch - either based upon original theses or transformative science - is attracting both brilliant and ambitious entrepreneurs. I'm delighted to be part of the organization"

In Energy, Lux is a founder or founding investor in sector leaders from energy efficient power conversion to nuclear waste remediation. Recent Lux Capital energy investments include Accelergy, Kurion, Siluria, and Transphorm. In Life Sciences, Lux is a founder or founding investor in sector leaders from rapid vaccine discovery to nano-enabled drug delivery. Recent Lux Capital life sciences investments include Cerulean Pharma, Genocea Biosciences, Kala Pharmaceuticals, and Visterra Therapeutics.

####

About Lux Capital
Lux Capital is a leading venture firm focused on founding, seed and early stage investments in emerging technologies. Lux takes an active role in helping entrepreneurs build successful businesses in Energy, Life Sciences and Technology. The Lux investment team has founded more than 20 companies from scratch, including Caliper, Genocea, Illumina, Kala, Kurion, Lux Research, Nanosys, Neurocrine, and Vertex Pharmaceuticals.

For more information, please click here

Contacts:
Bibi Masara
646-723-2217

Copyright © Lux Capital

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

A 'movie' of ultrafast rotating molecules at a hundred billion per second: A quantum wave-like nature was successfully observed in rotating nitrogen molecules July 4th, 2015

New Biosensor Produced in Iran to Detect Effective Drugs in Cancer Treatment July 4th, 2015

Clues to inner atomic life from subtle light-emission shifts: Hyperfine structure of light absorption by short-lived cadmium atom isotopes reveals characteristics of the nucleus that matter for high precision detection methods July 3rd, 2015

Pioneering Southampton scientist awarded prestigious physics medal July 3rd, 2015

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Harris & Harris Group Portfolio Company, AgBiome, Announces Partnership to Accelerate the Discovery of Next Generation Insect-Resistant Crops July 1st, 2015

Chivalrous Knight Does Pro Bono June 27th, 2015

Exagan Raises €5.7 Million to Produce High-efficiency GaN-on-Silicon Power-switching Devices on 200mm Wafers: Leti-and-Soitec Spinout Focused on Becoming Leading European Source Of GaN Devices for Solar, Automotive, Telecoms and Infrastructure June 25th, 2015

Harris & Harris Group Portfolio Company D-Wave Systems Announces 1,000 Qubit Processor and is Discussed in the Economist June 23rd, 2015

Nanomedicine

New Biosensor Produced in Iran to Detect Effective Drugs in Cancer Treatment July 4th, 2015

Groundbreaking research to help control liquids at micro and nano scales July 3rd, 2015

Iranian Scientists Find Simple, Economic Method to Synthesize Antibacterial Nanoparticles July 2nd, 2015

Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015

Announcements

A 'movie' of ultrafast rotating molecules at a hundred billion per second: A quantum wave-like nature was successfully observed in rotating nitrogen molecules July 4th, 2015

New Biosensor Produced in Iran to Detect Effective Drugs in Cancer Treatment July 4th, 2015

Clues to inner atomic life from subtle light-emission shifts: Hyperfine structure of light absorption by short-lived cadmium atom isotopes reveals characteristics of the nucleus that matter for high precision detection methods July 3rd, 2015

Pioneering Southampton scientist awarded prestigious physics medal July 3rd, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Angstron Materials Appoints VP for Business Development And Engineering June 27th, 2015

Solegear Further Strengthens its Product Development Team: New Hire Seeks to Create New, Disruptive, Sustainable Materials June 17th, 2015

Janusz Bryzek Joins MEMS Industry Group to Lead New TSensors Division - New Division will Focus on Accelerating Development of Emerging Ultra-high Volume Sensors Supporting Abundance, mHealth and IoT May 14th, 2015

Carbodeon Appoints Leading Industry Expert as Advisory Board Member May 7th, 2015

Energy

New technology using silver may hold key to electronics advances July 2nd, 2015

Visible Light-Sensitive Photocatalysts Used for Purification of Contaminated Water in Iran June 30th, 2015

June 29th, 2015

Making new materials with micro-explosions: ANU media release: Scientists have made exotic new materials by creating laser-induced micro-explosions in silicon, the common computer chip material June 29th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project